FiercePharma – Intent to focus on the first-ever gene therapy to launch in the U.S., Spark Therapeutics has licensed voretigene neparvovec to Novartis for development and commercialization for the rest of the world. In return, the newly commercial company is set to receive up to $170 million.
Bloomberg – Donald Trump’s administration is working “quite aggressively” to increase the use of renewable energy in the U.S. as part of the president’s plans to boost American energy independence, a senior adviser said during a fact-finding visit to Denmark.
Slate – “It drops the package. You come and get your package and we can do half-hour deliveries,” (Jeff) Bezos said, imagining that drone delivery could happen within five years. The biggest hurdle, he said, would be regulation.